The Balance and Vision Laboratory at Neuroscience Research Australia has developed a safe, non-invasive, rehabilitation technique that after a single 15 minute session can increase the vestibular (balance) response by up to 50%. They have shown that the technique can be administered using a portable device under a controlled setting. As part of that study they are seeking patients with well-defined, isolated, peripheral, vestibular lesions.
The study aims to determine whether exercises that aim to normalise function of your vestibulo-ocular reflex (VOR), which has been damaged due to injury of the vestibular organ/nerve, leads to improvements in your ability to stabilise vision during head movements, improves your balance, makes walking easier and generally improves your quality of life. You will be asked to take home an Australian developed rehabilitation device that will allow you to perform a 15 minute, once-daily, rehabilitation exercise. You will be asked to come to the laboratory once per month to measure your progress.
Each visit to the laboratory will take about two hours and consist of 5 parts:
If you are interested in being a subject or would like any further information please contact:
Dr. Americo Migliaccio
Tel: 02 9399 1030
The Balance and Vision lab at NeuRA have developed a safe, non-invasive rehabilitation technique and device that can improve the function of the vestibular (balance) system.
We’re now at a clinical trial phase to determine the effectiveness in balance, walking, general symptoms and vestibular nerve function in patients with well-defined, isolated, peripheral vestibular lesions.
Unfortunately, you’re NOT eligible if you suffer from
Additionally, you must be:
In Australia alone, 250,000 people are affected by bipolar disorder. Current treatments are highly variable for the severe and debilitating psychiatric condition and the specific genetic causes have remained largely obscure. Bipolar disorder is most commonly treated with lithium, but this is only effective for 30% of patients. Unlocking the genetic code of bipolar disorder and using pharmacogenomics studies to […]